RecruitingNCT07443826
CALM-AF-AI: Counteracting Age-related Loss of Muscle With AAV-Follistatin Combined With Angiogenesis-Inducing VEGF Plasmid Gene Therapy
PHASE1 · PHASE2 · 12 planned enrolment
- Countries listed
- 1
- Registry update
- July 13, 2026
Program Identity
UBL-CALMAF-001
Exact source-linked program identifier and related public trial registrations.
Unlimited Biotechnology LLC
UBL-CALMAF-001
1 exact source-linked registration. No aliases, synonyms, ownership, or cross-source equivalence are inferred.